| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Biochemistry, Department of Human Biological Chemistry and Genetics, The University of Texas Medical Branch, Galveston, Texas 77550
Phenylalanine ammonia-lyase from yeast was evaluated for its chemotherapeutic effectiveness against the murine L5178Y lymphoblastic leukemia maintained in C57BL/6 x DBA/2 F1 (BD2F1) mice. This enzyme, administered at concentrations of 300 units/kg, rapidly lowered plasma phenylalanine and tyrosine levels, inhibited tumor growth, and produced cures in 40% of the mice. Partially purified preparations of this enzyme, coupled with diets containing low levels of phenylalanine, significantly increased the average life-span of the mice and also produced cures. These results suggest that phenylalanine ammonia-lyase may be a valuable new chemotherapeutic agent for the treatment of some neoplasms.
1 This study was supported in part by USPHS Research Grant CA-11732 from the National Cancer Institute.
2 On sabbatical leave from the University of Oklahoma Health Sciences Center, Oklahoma City, Okla. 73190.
Received 7/ 2/73. Accepted 8/ 7/73.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |